Thrombophilia in patients with hypercholesterolemia

Metabolism: Clinical and Experimental

Volumn 45, Issue 8, 1996, Pages 966-969

  Chan, Paul ^a   Tomlinsoin, Brain ^a   Tsai, Chung Wen ^a   Pan, Wen Harn ^a   Lee, Ying Shiung ^a  

^a Department of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; PLASMINOGEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; THROMBOPHILIA; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029829118     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90264-4     Document Type: Article

References (26)

1. Heller RF, Chinn S, Tunstall-Pedoe HD, et al: How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J 288:1409-1411, 1984
2. Francis RB Jr: Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function. New York, NY, Marcel-Dekker, 1992
3. Lowe GDO: Laboratory investigation of pre-thrombotic states, in Poller L, Thomson JM (eds): Thrombosis and its management. Edinburg, UK, Churchill-Livingstone, 1993, pp 31-46
4. Branchi A, Rovellini A, Sommariva D, et al: Effects of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia. Thromb Haemost 70:241-243, 1993
5. Stuart J, George AJ, Davies AJ, et al: Hematological stress syndrome in atherosclerosis. J Clin Pathol 34:464-467, 1981
6. Tyroler HA: Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation 76:515-522, 1987
7. Miller GJ: Lipoproteins and the hemostatic system in atherothrombotic disorders. Baillieres Clin Haematol 7:713-732, 1994
8. Folsom AR, Wu KK, Davis CE, et al: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 91:191-205, 1991
9. Folsom AR, Conlan MG, Davis CE, et al: Relations between hemostasis variables and cardiovascular risk factors in middle-age adults. Ann Epidemiol 2:471-480, 1992
10. Balleisen L, Assmann G, Bailey J, et al: Epidemiological study on factor VII, factor III and fibrinogen in an industrial population II. Baseline data in relation to blood pressure, blood glucose, uric acid and lipid fractions. Thromb Haemost 54:721-723, 1985
11. Yeh CJ, Pan WH, Bai CH, et al: Curvilinear relationships between age and hemostatic parameters in Chinese. Thromb Haemost 70:239-243, 1993
12. Chan P, Pan WH: Coagulation activation in type 2 diabetes mellitus: The higher coronary risk of female diabetic patients. Diabetic Med 12:504-507, 1995
13. Chan P, Lin TH, Pan WH, et al: Thrombophilia associated with obesity in ethnic Chinese. Int J Obes 19:756-759, 1995
14. Kannel WB, D'Agostino RB, Belanger AJ: Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol 2:457-466, 1992
15. Meade TW, Mellows S, Brozovic M: Hemostatic function and ischemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 2:533-537, 1986
16. Meade TW, North WRS, Chakrabarti RR, et al: Haemostatic function and cardiovascular death: Early result of a prospective study. Lancet 1:1050-1054, 1980
17. Anderson KM, Wilson PW, Odell PM, et al: An updated coronary risk profile. A statement for health professionals. AHA Medical/Scientific Statement Science Advisory. Circulation 83:356-362, 1991
18. Hamsten A: The hemostatic system and coronary heart disease. Thromb Res 70:1-38, 1993
19. Meade TW, Ruddock V, Stirling Y, et al: Fibrinolytic activity, clotting factors, and long-term incidence of ischemiC heart disease in the Northwick Park Heart Study. Lancet 342:1076-1079, 1993
20. Meade TW, Copper JA, Stirling Y, et al: Factor VIIIc ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 88:601-607, 1994
21. Wessler S: Oestrogen-associated thromboembolism. Ann Epidemiol 2:439-443, 1992
22. Almer LO, Pandolfi M: Fibrinolysis and diabetic retinopathy. Diabetes 25:807-810, 1976 (suppl 2)
23. Fuller JH, Keen H, Jarrett RJ, et al: Hemostatic variables associated with diabetes and its complications. Br Med J 2:964-966, 1979
24. Lucas MA, Fretto LJ, Kckee PA: The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 258:4249-4256, 1983
25. Reaven GM: Role of insulin resistance in human disease in multiple risk factors in cardiovascular disease, in Gotto AM, Lenfant C, Paoletti R, et al (eds): Giovanni Lorenzino Medical Foundation. Dordrecht, The Netherlands, Kluwer Academic, 1992, pp 91-97
26. Mitchell BD, Haffner SM, Hazuda HP, et al: The relationship between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol 136:12-22, 1992